nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0384	0.0904	CbGeAlD
Cabergoline—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.0285	0.0516	CcSEcCtD
Cabergoline—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.0208	0.0489	CbGeAlD
Cabergoline—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.0203	0.0367	CcSEcCtD
Cabergoline—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.0202	0.0474	CbGeAlD
Cabergoline—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.0188	0.0341	CcSEcCtD
Cabergoline—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.0183	0.0331	CcSEcCtD
Cabergoline—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0174	0.0315	CcSEcCtD
Cabergoline—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0161	0.0291	CcSEcCtD
Cabergoline—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.0161	0.0377	CbGeAlD
Cabergoline—HTR7—pons—amyotrophic lateral sclerosis	0.0159	0.0373	CbGeAlD
Cabergoline—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0256	CcSEcCtD
Cabergoline—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0245	CcSEcCtD
Cabergoline—DRD1—nerve—amyotrophic lateral sclerosis	0.0132	0.031	CbGeAlD
Cabergoline—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0227	CcSEcCtD
Cabergoline—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0205	CcSEcCtD
Cabergoline—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0194	CcSEcCtD
Cabergoline—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0192	CcSEcCtD
Cabergoline—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.0106	0.0248	CbGeAlD
Cabergoline—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0185	CcSEcCtD
Cabergoline—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.01	0.0235	CbGeAlD
Cabergoline—HTR2A—pons—amyotrophic lateral sclerosis	0.00989	0.0233	CbGeAlD
Cabergoline—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00917	0.0166	CcSEcCtD
Cabergoline—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00895	0.0162	CcSEcCtD
Cabergoline—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00888	0.0161	CcSEcCtD
Cabergoline—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00874	0.0158	CcSEcCtD
Cabergoline—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00864	0.0156	CcSEcCtD
Cabergoline—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00844	0.0198	CbGeAlD
Cabergoline—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00827	0.015	CcSEcCtD
Cabergoline—HTR7—nerve—amyotrophic lateral sclerosis	0.00823	0.0193	CbGeAlD
Cabergoline—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00818	0.0148	CcSEcCtD
Cabergoline—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00792	0.0143	CcSEcCtD
Cabergoline—DRD2—nerve—amyotrophic lateral sclerosis	0.00778	0.0183	CbGeAlD
Cabergoline—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00774	0.0182	CbGeAlD
Cabergoline—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00774	0.014	CcSEcCtD
Cabergoline—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00744	0.0135	CcSEcCtD
Cabergoline—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00742	0.0134	CcSEcCtD
Cabergoline—HTR2A—appendage—amyotrophic lateral sclerosis	0.00724	0.017	CbGeAlD
Cabergoline—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00704	0.0127	CcSEcCtD
Cabergoline—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.007	0.0127	CcSEcCtD
Cabergoline—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00694	0.0126	CcSEcCtD
Cabergoline—Depression—Riluzole—amyotrophic lateral sclerosis	0.00688	0.0125	CcSEcCtD
Cabergoline—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00671	0.0121	CcSEcCtD
Cabergoline—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00658	0.0155	CbGeAlD
Cabergoline—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00651	0.0118	CcSEcCtD
Cabergoline—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00645	0.0152	CbGeAlD
Cabergoline—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00621	0.0112	CcSEcCtD
Cabergoline—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00616	0.0145	CbGeAlD
Cabergoline—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00616	0.0112	CcSEcCtD
Cabergoline—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0061	0.011	CcSEcCtD
Cabergoline—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00595	0.014	CbGeAlD
Cabergoline—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00583	0.0137	CbGeAlD
Cabergoline—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00575	0.0104	CcSEcCtD
Cabergoline—DRD1—brainstem—amyotrophic lateral sclerosis	0.00565	0.0133	CbGeAlD
Cabergoline—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00553	0.01	CcSEcCtD
Cabergoline—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00547	0.00991	CcSEcCtD
Cabergoline—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00531	0.00962	CcSEcCtD
Cabergoline—Tension—Riluzole—amyotrophic lateral sclerosis	0.00529	0.00958	CcSEcCtD
Cabergoline—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00524	0.00948	CcSEcCtD
Cabergoline—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00522	0.00944	CcSEcCtD
Cabergoline—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00518	0.00938	CcSEcCtD
Cabergoline—HTR2A—nerve—amyotrophic lateral sclerosis	0.00513	0.0121	CbGeAlD
Cabergoline—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.005	0.00905	CcSEcCtD
Cabergoline—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00486	0.0088	CcSEcCtD
Cabergoline—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00877	CcSEcCtD
Cabergoline—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00875	CcSEcCtD
Cabergoline—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00476	0.00862	CcSEcCtD
Cabergoline—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00474	0.00858	CcSEcCtD
Cabergoline—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00842	CcSEcCtD
Cabergoline—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00459	0.00831	CcSEcCtD
Cabergoline—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00458	0.0108	CbGeAlD
Cabergoline—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00457	0.00828	CcSEcCtD
Cabergoline—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00454	0.00821	CcSEcCtD
Cabergoline—DRD4—brain—amyotrophic lateral sclerosis	0.0045	0.0106	CbGeAlD
Cabergoline—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00812	CcSEcCtD
Cabergoline—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00444	0.00803	CcSEcCtD
Cabergoline—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00444	0.0104	CbGeAlD
Cabergoline—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0044	0.00796	CcSEcCtD
Cabergoline—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00439	0.0103	CbGeAlD
Cabergoline—Shock—Riluzole—amyotrophic lateral sclerosis	0.00433	0.00784	CcSEcCtD
Cabergoline—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00425	0.0077	CcSEcCtD
Cabergoline—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00419	0.00759	CcSEcCtD
Cabergoline—DRD3—nervous system—amyotrophic lateral sclerosis	0.00414	0.00972	CbGeAlD
Cabergoline—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00411	0.00744	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00726	CcSEcCtD
Cabergoline—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00398	0.00936	CbGeAlD
Cabergoline—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00398	0.0072	CcSEcCtD
Cabergoline—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00715	CcSEcCtD
Cabergoline—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00392	0.0071	CcSEcCtD
Cabergoline—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00708	CcSEcCtD
Cabergoline—DRD5—nervous system—amyotrophic lateral sclerosis	0.00388	0.00911	CbGeAlD
Cabergoline—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00701	CcSEcCtD
Cabergoline—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00384	0.00904	CbGeAlD
Cabergoline—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00692	CcSEcCtD
Cabergoline—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00379	0.00687	CcSEcCtD
Cabergoline—Pain—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00681	CcSEcCtD
Cabergoline—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00681	CcSEcCtD
Cabergoline—DRD5—central nervous system—amyotrophic lateral sclerosis	0.00373	0.00877	CbGeAlD
Cabergoline—HTR1A—brainstem—amyotrophic lateral sclerosis	0.0037	0.00869	CbGeAlD
Cabergoline—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00656	CcSEcCtD
Cabergoline—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00651	CcSEcCtD
Cabergoline—HTR7—brainstem—amyotrophic lateral sclerosis	0.00353	0.0083	CbGeAlD
Cabergoline—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0063	CcSEcCtD
Cabergoline—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00341	0.00801	CbGeAlD
Cabergoline—DRD2—brainstem—amyotrophic lateral sclerosis	0.00334	0.00785	CbGeAlD
Cabergoline—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00587	CcSEcCtD
Cabergoline—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00318	0.00747	CbGeAlD
Cabergoline—DRD3—brain—amyotrophic lateral sclerosis	0.00316	0.00743	CbGeAlD
Cabergoline—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00571	CcSEcCtD
Cabergoline—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00563	CcSEcCtD
Cabergoline—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.00311	0.00731	CbGeAlD
Cabergoline—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00306	0.0072	CbGeAlD
Cabergoline—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00306	0.00719	CbGeAlD
Cabergoline—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00545	CcSEcCtD
Cabergoline—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00299	0.00704	CbGeAlD
Cabergoline—DRD5—brain—amyotrophic lateral sclerosis	0.00296	0.00697	CbGeAlD
Cabergoline—DRD1—nervous system—amyotrophic lateral sclerosis	0.00296	0.00696	CbGeAlD
Cabergoline—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00527	CcSEcCtD
Cabergoline—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00285	0.0067	CbGeAlD
Cabergoline—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00285	0.0067	CbGeAlD
Cabergoline—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00506	CcSEcCtD
Cabergoline—Rash—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00502	CcSEcCtD
Cabergoline—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00502	CcSEcCtD
Cabergoline—Headache—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00499	CcSEcCtD
Cabergoline—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00273	0.00642	CbGeAlD
Cabergoline—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00473	CcSEcCtD
Cabergoline—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00246	0.00579	CbGeAlD
Cabergoline—ADRA1B—brain—amyotrophic lateral sclerosis	0.00243	0.00571	CbGeAlD
Cabergoline—HTR2A—embryo—amyotrophic lateral sclerosis	0.0024	0.00565	CbGeAlD
Cabergoline—HTR1B—nervous system—amyotrophic lateral sclerosis	0.0024	0.00564	CbGeAlD
Cabergoline—ADRA1D—brain—amyotrophic lateral sclerosis	0.00238	0.00559	CbGeAlD
Cabergoline—HTR1D—nervous system—amyotrophic lateral sclerosis	0.00232	0.00546	CbGeAlD
Cabergoline—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00231	0.00543	CbGeAlD
Cabergoline—HTR2C—nervous system—amyotrophic lateral sclerosis	0.0023	0.00541	CbGeAlD
Cabergoline—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.0023	0.0054	CbGeAlD
Cabergoline—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00226	0.00532	CbGeAlD
Cabergoline—DRD1—brain—amyotrophic lateral sclerosis	0.00226	0.00532	CbGeAlD
Cabergoline—ADRB1—nervous system—amyotrophic lateral sclerosis	0.00226	0.00531	CbGeAlD
Cabergoline—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00224	0.00526	CbGeAlD
Cabergoline—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00222	0.00521	CbGeAlD
Cabergoline—HTR2A—brainstem—amyotrophic lateral sclerosis	0.0022	0.00518	CbGeAlD
Cabergoline—HTR7—spinal cord—amyotrophic lateral sclerosis	0.0022	0.00516	CbGeAlD
Cabergoline—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.00217	0.00511	CbGeAlD
Cabergoline—HTR2B—nervous system—amyotrophic lateral sclerosis	0.00216	0.00508	CbGeAlD
Cabergoline—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00208	0.00489	CbGeAlD
Cabergoline—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00202	0.00475	CbGeAlD
Cabergoline—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00194	0.00455	CbGeAlD
Cabergoline—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00186	0.00438	CbGeAlD
Cabergoline—HTR7—nervous system—amyotrophic lateral sclerosis	0.00185	0.00435	CbGeAlD
Cabergoline—HTR1B—brain—amyotrophic lateral sclerosis	0.00183	0.00431	CbGeAlD
Cabergoline—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00182	0.00428	CbGeAlD
Cabergoline—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00181	0.00425	CbGeAlD
Cabergoline—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00179	0.0042	CbGeAlD
Cabergoline—HTR7—central nervous system—amyotrophic lateral sclerosis	0.00178	0.00419	CbGeAlD
Cabergoline—HTR1D—brain—amyotrophic lateral sclerosis	0.00178	0.00418	CbGeAlD
Cabergoline—HTR2C—brain—amyotrophic lateral sclerosis	0.00176	0.00413	CbGeAlD
Cabergoline—DRD2—nervous system—amyotrophic lateral sclerosis	0.00175	0.00411	CbGeAlD
Cabergoline—HTR7—cerebellum—amyotrophic lateral sclerosis	0.00174	0.00409	CbGeAlD
Cabergoline—ADRB1—brain—amyotrophic lateral sclerosis	0.00173	0.00406	CbGeAlD
Cabergoline—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00172	0.00404	CbGeAlD
Cabergoline—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.0017	0.004	CbGeAlD
Cabergoline—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00168	0.00396	CbGeAlD
Cabergoline—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00168	0.00395	CbGeAlD
Cabergoline—HTR2B—brain—amyotrophic lateral sclerosis	0.00165	0.00388	CbGeAlD
Cabergoline—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00165	0.00387	CbGeAlD
Cabergoline—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.00164	0.00385	CbGeAlD
Cabergoline—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00161	0.00379	CbGeAlD
Cabergoline—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.0016	0.00376	CbGeAlD
Cabergoline—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00154	0.00361	CbGeAlD
Cabergoline—HTR1A—brain—amyotrophic lateral sclerosis	0.00148	0.00348	CbGeAlD
Cabergoline—HTR7—brain—amyotrophic lateral sclerosis	0.00141	0.00333	CbGeAlD
Cabergoline—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.00137	0.00322	CbGeAlD
Cabergoline—ADRA1A—brain—amyotrophic lateral sclerosis	0.00136	0.00321	CbGeAlD
Cabergoline—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00136	0.00319	CbGeAlD
Cabergoline—DRD2—brain—amyotrophic lateral sclerosis	0.00134	0.00314	CbGeAlD
Cabergoline—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00131	0.00307	CbGeAlD
Cabergoline—ADRA2C—brain—amyotrophic lateral sclerosis	0.0013	0.00306	CbGeAlD
Cabergoline—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00128	0.003	CbGeAlD
Cabergoline—HTR2A—nervous system—amyotrophic lateral sclerosis	0.00115	0.00271	CbGeAlD
Cabergoline—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.00111	0.00261	CbGeAlD
Cabergoline—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.00109	0.00255	CbGeAlD
Cabergoline—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00107	0.00251	CbGeAlD
Cabergoline—ADRA2A—brain—amyotrophic lateral sclerosis	0.00104	0.00244	CbGeAlD
Cabergoline—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00103	0.00242	CbGeAlD
Cabergoline—HTR2A—brain—amyotrophic lateral sclerosis	0.000882	0.00207	CbGeAlD
Cabergoline—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.13e-05	0.000513	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.13e-05	0.000513	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.11e-05	0.000504	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.11e-05	0.000502	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.1e-05	0.000499	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.1e-05	0.000499	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.1e-05	0.000498	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.1e-05	0.000497	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.1e-05	0.000497	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.09e-05	0.000495	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.09e-05	0.000494	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.09e-05	0.000492	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.09e-05	0.000492	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.09e-05	0.000492	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.09e-05	0.000491	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.08e-05	0.000491	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.08e-05	0.000491	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.08e-05	0.000487	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.06e-05	0.000482	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.06e-05	0.000481	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.06e-05	0.00048	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.05e-05	0.000477	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.05e-05	0.000474	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.04e-05	0.00047	CbGpPWpGaD
Cabergoline—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.03e-05	0.000468	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.03e-05	0.000466	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.03e-05	0.000465	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.03e-05	0.000464	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.02e-05	0.000462	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.02e-05	0.00046	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000459	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.01e-05	0.000457	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1e-05	0.000453	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1e-05	0.000453	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1e-05	0.000452	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.94e-06	0.00045	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.9e-06	0.000448	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.89e-06	0.000448	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.87e-06	0.000447	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.85e-06	0.000446	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.85e-06	0.000446	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.81e-06	0.000444	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.69e-06	0.000438	CbGpPWpGaD
Cabergoline—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	9.66e-06	0.000437	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.65e-06	0.000436	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.62e-06	0.000435	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.6e-06	0.000434	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.47e-06	0.000429	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.47e-06	0.000429	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.43e-06	0.000427	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.42e-06	0.000426	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.4e-06	0.000425	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.31e-06	0.000421	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.3e-06	0.000421	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.3e-06	0.000421	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.16e-06	0.000415	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.16e-06	0.000414	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.09e-06	0.000411	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.07e-06	0.00041	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.03e-06	0.000409	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.02e-06	0.000408	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.97e-06	0.000406	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.96e-06	0.000406	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.86e-06	0.000401	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.84e-06	0.0004	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.82e-06	0.000399	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.75e-06	0.000396	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.75e-06	0.000396	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.73e-06	0.000395	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.7e-06	0.000394	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.59e-06	0.000389	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.47e-06	0.000383	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.46e-06	0.000383	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.41e-06	0.000381	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.41e-06	0.00038	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.4e-06	0.00038	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.33e-06	0.000377	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.32e-06	0.000376	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.31e-06	0.000376	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.29e-06	0.000375	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.23e-06	0.000372	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.18e-06	0.00037	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	8.15e-06	0.000369	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.11e-06	0.000367	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.1e-06	0.000367	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.06e-06	0.000365	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.01e-06	0.000363	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.97e-06	0.000361	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.9e-06	0.000357	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.85e-06	0.000355	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.84e-06	0.000355	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.83e-06	0.000354	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.82e-06	0.000354	CbGpPWpGaD
Cabergoline—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	7.81e-06	0.000354	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.8e-06	0.000353	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.79e-06	0.000353	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.73e-06	0.00035	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.73e-06	0.00035	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.73e-06	0.00035	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.72e-06	0.000349	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.62e-06	0.000345	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.58e-06	0.000343	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	7.53e-06	0.000341	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.44e-06	0.000337	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.37e-06	0.000334	CbGpPWpGaD
Cabergoline—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	7.3e-06	0.00033	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.29e-06	0.00033	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.26e-06	0.000328	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	7.26e-06	0.000328	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.2e-06	0.000326	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.2e-06	0.000326	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.16e-06	0.000324	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.12e-06	0.000322	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.04e-06	0.000319	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7e-06	0.000317	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.99e-06	0.000316	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.98e-06	0.000316	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.98e-06	0.000316	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.95e-06	0.000314	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.89e-06	0.000312	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.86e-06	0.00031	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.8e-06	0.000308	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.74e-06	0.000305	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.7e-06	0.000303	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.69e-06	0.000303	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.69e-06	0.000303	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.6e-06	0.000299	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.58e-06	0.000298	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.56e-06	0.000297	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.52e-06	0.000295	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.5e-06	0.000294	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.45e-06	0.000292	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.41e-06	0.00029	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.41e-06	0.00029	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.39e-06	0.000289	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.37e-06	0.000288	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.27e-06	0.000284	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.24e-06	0.000282	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	6.18e-06	0.00028	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.07e-06	0.000275	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.03e-06	0.000273	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.99e-06	0.000271	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.97e-06	0.00027	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.95e-06	0.000269	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.95e-06	0.000269	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	5.93e-06	0.000268	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.92e-06	0.000268	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.91e-06	0.000268	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	5.89e-06	0.000267	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.82e-06	0.000263	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.7e-06	0.000258	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.51e-06	0.000249	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.42e-06	0.000245	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.42e-06	0.000245	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.38e-06	0.000244	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.37e-06	0.000243	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.35e-06	0.000242	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.3e-06	0.00024	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.3e-06	0.00024	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.29e-06	0.00024	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.24e-06	0.000237	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.18e-06	0.000234	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.16e-06	0.000233	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.15e-06	0.000233	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.09e-06	0.00023	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.05e-06	0.000229	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.01e-06	0.000227	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.97e-06	0.000225	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.95e-06	0.000224	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.93e-06	0.000223	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.93e-06	0.000223	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.92e-06	0.000223	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.87e-06	0.00022	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.65e-06	0.00021	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.64e-06	0.00021	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.58e-06	0.000207	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.58e-06	0.000207	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.57e-06	0.000207	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.55e-06	0.000206	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.54e-06	0.000205	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.48e-06	0.000203	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.48e-06	0.000203	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.44e-06	0.000201	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.38e-06	0.000198	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.38e-06	0.000198	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.37e-06	0.000198	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.32e-06	0.000196	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.32e-06	0.000196	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.17e-06	0.000189	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.17e-06	0.000189	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.13e-06	0.000187	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.08e-06	0.000185	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.07e-06	0.000184	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.04e-06	0.000183	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.99e-06	0.00018	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.97e-06	0.00018	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.94e-06	0.000178	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.94e-06	0.000178	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.9e-06	0.000177	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.88e-06	0.000176	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.88e-06	0.000176	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.86e-06	0.000175	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.85e-06	0.000174	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.8e-06	0.000172	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.77e-06	0.000171	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.75e-06	0.00017	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.65e-06	0.000165	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.59e-06	0.000162	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.54e-06	0.00016	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.51e-06	0.000159	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.5e-06	0.000158	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.46e-06	0.000157	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.45e-06	0.000156	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.45e-06	0.000156	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.43e-06	0.000155	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.38e-06	0.000153	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.37e-06	0.000153	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.37e-06	0.000152	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.36e-06	0.000152	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.32e-06	0.00015	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.31e-06	0.00015	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.3e-06	0.000149	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.28e-06	0.000148	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.26e-06	0.000147	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.22e-06	0.000146	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.19e-06	0.000144	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.15e-06	0.000143	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.13e-06	0.000142	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.05e-06	0.000138	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.97e-06	0.000135	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.97e-06	0.000134	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.96e-06	0.000134	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.93e-06	0.000133	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.93e-06	0.000133	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.92e-06	0.000132	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.86e-06	0.00013	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.67e-06	0.000121	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.66e-06	0.00012	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.65e-06	0.00012	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.62e-06	0.000118	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.56e-06	0.000116	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.54e-06	0.000115	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.51e-06	0.000114	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.47e-06	0.000112	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.44e-06	0.00011	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.25e-06	0.000102	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.21e-06	0.0001	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.16e-06	9.79e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.01e-06	9.1e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.72e-06	7.79e-05	CbGpPWpGaD
